PMC:7031805 / 24750-25429 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7031805","sourcedb":"PMC","sourceid":"7031805","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7031805","text":"Taken to its logical albeit futuristic conclusion, one might envision a paradigm shift from ASMs in the form of multiple doses of a drug per day and steady-state blood levels (with attendant side effects) to delivery systems that provide anticonvulsants to the brain at the site they are needed and only when they are needed, improving the quality of life of the patient. Further, each patient’s treatment would be customized based on genetic and molecular profiles. This form of precision medicine would eliminate the need for chronic and systemic nonspecific and side effect-laden pharmacotherapy, improving efficacy and possibly reducing the development of pharmacoresistance.","tracks":[{"project":"testtesttest","denotations":[{"id":"T48","span":{"begin":162,"end":167},"obj":"Body_part"},{"id":"T49","span":{"begin":217,"end":224},"obj":"Body_part"},{"id":"T50","span":{"begin":257,"end":266},"obj":"Body_part"}],"attributes":[{"id":"A48","pred":"uberon_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A49","pred":"uberon_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/UBERON_0000467"},{"id":"A50","pred":"uberon_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"subj":"T48","pred":"source","obj":"testtesttest"},{"subj":"T49","pred":"source","obj":"testtesttest"},{"subj":"T50","pred":"source","obj":"testtesttest"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"testtesttest","color":"#93ecdc","default":true}]}]}}